e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
5
6
Next >
Confidence Boost From Ingrezza Sales: Analyst Upgrades Neurocrine Biosciences
July 06, 2023
Tickers
NBIX
VYGR
Tags
VYGR
Briefs
Trading Ideas
From
Benzinga
What To Know About BMO Capital's Upgrade of Neurocrine Biosciences
July 06, 2023
Tickers
NBIX
Tags
NBIX
Analyst Ratings
BZI/AAR/UPDATE
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
July 06, 2023
Tickers
AEL
AFRM
AJX
AMED
Tags
FHN
CARM
Analyst Ratings
From
Benzinga
Expert Ratings for Neurocrine Biosciences
June 30, 2023
Tickers
NBIX
Tags
Benzinga
Market News
BZI/AAR
From
Benzinga
What 15 Analyst Ratings Have To Say About Neurocrine Biosciences
June 05, 2023
Tickers
NBIX
Tags
Analyst Ratings
NBIX
BZI/AAR
From
Benzinga
Neurocrine Biosciences's Return On Capital Employed Overview
May 08, 2023
Tickers
NBIX
Tags
Earnings
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
RVLV
WIX
ZI
From
Benzinga
Neurocrine Biosciences Clocks 35% Revenue Growth In Q1, Misses On Bottom-Line Performance
May 03, 2023
Tickers
NBIX
Tags
Markets
Health Care
NBIX
From
Benzinga
Neurocrine Biosciences: Q1 Earnings Insights
May 03, 2023
Tickers
NBIX
Tags
NBIX
Earnings
Market News
From
Benzinga
Neurocrine Biosciences's Earnings: A Preview
May 02, 2023
Tickers
NBIX
Tags
NBIX
BZI/EP
Market News
From
Benzinga
3 Pharma Stocks That Could See a Surge in Demand in 2023
April 24, 2023
Tickers
ALNY
MRK
NBIX
Tags
Stocks to Buy
NBIX
MRK
From
InvestorPlace
What 15 Analyst Ratings Have To Say About Neurocrine Biosciences
April 17, 2023
Tickers
NBIX
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Expert Ratings for Neurocrine Biosciences
March 30, 2023
Tickers
NBIX
Tags
Benzinga
Market News
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Tickers
AMT
APLE
BCEL
CCI
Tags
IPG
ERAS
ITGR
From
Benzinga
3 Growth Stocks That Could Disrupt the Healthcare Industry
March 13, 2023
Tickers
ALNY
NBIX
SGFY
Tags
Stocks to Buy
NBIX
Market News
From
InvestorPlace
Analyst Expectations for Neurocrine Biosciences's Future
March 03, 2023
Tickers
NBIX
Tags
Benzinga
Market News
NBIX
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
March 03, 2023
Tickers
AIMC
ARDX
ASAN
BILI
Tags
CHK
PG
ARDX
From
Benzinga
Earnings Scheduled For February 6, 2023
February 06, 2023
Tickers
ACM
ACT
ALCO
AMG
Tags
TTWO
VRNS
NSSC
From
Benzinga
Neurocrine Biosciences Earnings Preview
February 03, 2023
Tickers
NBIX
Tags
NBIX
BZI/EP
Earnings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Tickers
AGIO
AI
ALGN
APTV
Tags
ESPR
HLF
PRVA
From
Benzinga
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
February 03, 2023
Tickers
CERE
KRTX
NBIX
Tags
Analyst Ratings
Analyst Color
Health Care
From
Benzinga
7 A-Rated Stocks to Buy for Less Than $25
January 24, 2023
Tickers
AAC
AACI
ABGI
ACBA
Tags
VYGR
ACBA
ABGI
From
InvestorPlace
Why Voyager Therapeutics Stock Is Sinking This Week
January 20, 2023
Tickers
NBIX
VYGR
Tags
NBIX
Recent Press Releases
Market News
From
Motley Fool
Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal
January 09, 2023
Tickers
NBIX
VYGR
Tags
NBIX
NASDAQ:VYGR,NASDAQ:NBIX
Today's Market
From
InvestorPlace
Neurocrine Biosciences, Voyager Therapeutics Collaborate For Neurological-Focused Gene Therapies
January 09, 2023
Tickers
NBIX
VYGR
Tags
Large Cap
Biotechnology
General
From
Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
December 25, 2022
Tickers
ALBO
KDNY
KRYS
NBIX
Tags
Benzinga
Market News
KDNY
From
Benzinga
Despite Neurocrine's Epilepsy Drug Missing Primary Goal In Pediatric Trial, Analyst Sees Strong Growth
December 07, 2022
Tickers
NBIX
Tags
Biotechnology
General
Biotech
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
Tickers
ABC
ACGL
ACM
ADP
Tags
MSI
FTI
AVDL
From
Benzinga
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
November 23, 2022
Tickers
APLS
BHVN
BIIB
CCXI
Tags
Biotechnology
General
Biotech
From
Benzinga
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
November 14, 2022
Tickers
CTMX
ELAN
GANX
HSKA
Tags
News
MTH
HSKA
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.